127 related articles for article (PubMed ID: 37076132)
21. Gastric neuroendocrine tumors in our institutions according to the WHO 2010 classification.
Endo S; Dousei T; Yoshikawa Y; Hatanaka N; Taniyama K; Yamauchi A; Kamiike W; Nishijima J
Int Surg; 2012; 97(4):335-9. PubMed ID: 23294075
[TBL] [Abstract][Full Text] [Related]
22. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
Feng M; Zou J; Zhang Y; Sun L
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
[No Abstract] [Full Text] [Related]
23. Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas.
Koh J; Nam SK; Kwak Y; Kim G; Kim KK; Lee BC; Ahn SH; Park DJ; Kim HH; Park KU; Kim WH; Lee HS
J Pathol; 2021 Jan; 253(1):94-105. PubMed ID: 32985687
[TBL] [Abstract][Full Text] [Related]
24. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
25. Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach.
Choi NY; Kim BS; Oh ST; Yook JH; Kim BS
Am Surg; 2021 Apr; 87(4):631-637. PubMed ID: 33142079
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M
Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515
[TBL] [Abstract][Full Text] [Related]
27. Modified AJCC staging of gastric neuroendocrine carcinoma based on T staging can improve the capacity of prognosis assessment.
Xie JW; Li P; Wang JB; Lin JX; Lu J; Chen QY; Yang YH; Kang DY; Zheng CH; Huang CM
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2391-2397. PubMed ID: 30209612
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
[TBL] [Abstract][Full Text] [Related]
29. Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Merola E; Rinke A; Partelli S; Gress TM; Andreasi V; Kollár A; Perren A; Christ E; Panzuto F; Pascher A; Jann H; Arsenic R; Cremer B; Kaemmerer D; Kump P; Lipp RW; Agaimy A; Wiedenmann B; Falconi M; Pavel ME
Ann Surg Oncol; 2020 May; 27(5):1348-1355. PubMed ID: 31720931
[TBL] [Abstract][Full Text] [Related]
30. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K
Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015
[TBL] [Abstract][Full Text] [Related]
31. Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model.
Vale L; Kunonga P; Coughlan D; Kontogiannis V; Astin M; Beyer F; Richmond C; Wilson D; Bajwa D; Javanbakht M; Bryant A; Akor W; Craig D; Lovat P; Labus M; Nasr B; Cunliffe T; Hinde H; Shawgi M; Saleh D; Royle P; Steward P; Lucas R; Ellis R
Health Technol Assess; 2021 Nov; 25(64):1-178. PubMed ID: 34792018
[TBL] [Abstract][Full Text] [Related]
32. Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms.
Iwasaki K; Barroga E; Enomoto M; Tsurui K; Shimoda Y; Matsumoto M; Miyoshi K; Ota Y; Matsubayashi J; Nagakawa Y
World J Surg Oncol; 2022 May; 20(1):165. PubMed ID: 35610656
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathological features and prognosis of patients with gastric neuroendocrine carcinoma from multiple centers in southern China].
Fang C; Wang W; Zhang Y; Feng X; Zeng Y; Li Y; Chen J; Chen Y; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1230-1234. PubMed ID: 27928791
[TBL] [Abstract][Full Text] [Related]
35. Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma.
Wei B; Ding T; Xing Y; Wei W; Tian Z; Tang F; Abraham S; Nayeemuddin K; Hunt K; Wu Y
Cancer; 2010 Oct; 116(19):4463-73. PubMed ID: 20572042
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for metastasis and survival of patients with T1 gastric neuroendocrine carcinoma treated with endoscopic therapy versus surgical resection.
Ye H; Yuan Y; Chen P; Zheng Q
Surg Endosc; 2022 Aug; 36(8):6162-6169. PubMed ID: 35507062
[TBL] [Abstract][Full Text] [Related]
37. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
[TBL] [Abstract][Full Text] [Related]
38. Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model.
Choi E; Luo SJ; Ding VY; Wu JT; Kumar AV; Wampfler J; Tammemägi MC; Wilkens LR; Aredo JV; Backhus LM; Neal JW; Leung AN; Freedman ND; Hung RJ; Amos CI; Le Marchand L; Cheng I; Wakelee HA; Yang P; Han SS
Cancer; 2024 Mar; 130(5):770-780. PubMed ID: 37877788
[TBL] [Abstract][Full Text] [Related]
39. Conversion surgery after extensive chemotherapy for stage IV mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: clinical implications from the patterns of response and recurrence.
Kamei K; Shindoh J; Kiya Y; Matsumoto I; Hashimoto M; Takeyama Y
Clin J Gastroenterol; 2020 Apr; 13(2):240-246. PubMed ID: 31617127
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic analysis of 42 patients with gastric neuroendocrine carcinoma].
Kou Y; Gao YB; Ma J; Yang K; Fu Q; Xie JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):570-3. PubMed ID: 23801213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]